| answer text |
<p>Public Health England (PHE) has a comprehensive range of action aimed at reducing
the incidence and mortality from liver disease. It monitors the incidence, mortality
and outcomes of treatment for liver disease and the risk factors: alcohol obesity
and hepatitis B and C. PHE has a wide range of action to tackle unhealthy alcohol
consumption, obesity and viral hepatitis through strengthening local action, promoting
healthy choices, and giving appropriate information to support healthier lives.</p><p>
</p><p> </p><p> </p><p>In response to the All Party Parliamentary Hepatology Group
report PHE has committed to producing a PHE Liver Disease Framework. This will focus
on public health action to tackle risk factors for liver disease and inequalities
in relation to liver disease. Work has already begun to bring together expertise within
PHE on the major risk factors for liver disease (alcohol, hepatitis B and C and obesity),
data on liver disease and its risk factors and on death and dying from liver disease.
PHE has also issued liver profiles to each local authority area, which include information
about hepatitis C, as well as modelling tools to assist local commissioners in establishing
need at local level. Many of the actions to tackle the major risk factors require
a coordinated approach between PHE and NHS England.</p><p> </p><p> </p><p> </p><p>NHS
England is responsible for delivering improvements in outcomes against the NHS Mandate
and in line with the NHS Outcomes Framework. NHS England is adopting a broad strategy
for delivering improvements in relation to premature mortality, working with commissioners
and PHE to support clinical commissioning groups in understanding where local challenges
lie and in identifying the evidence in relation to the priorities for reducing mortality
at a national level.</p><p> </p>
|
|
